In March 2025, the company declared new plans for the direct-to-buyer featuring of its Wegovy weight loss drug. The company proven a new pharmacy, referred to as NovoCare, which would cost prospects $499 monthly for entry to the drug, below fifty percent the cost of the drug via other pharmaceutical distribution networks.[fifty three]Thank you for